N-lorem Foundation
Clinical trials sponsored by N-lorem Foundation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Custom-Made genetic drug targets rare brain disease in first human test Results expected Nov 2026 (estimated)
- Custom drug targets rare genetic brain condition in one patient Results expected Feb 2027 (estimated)
- Custom drug targets rare genetic brain disease in First-Ever human test Results expected Feb 2027 (estimated)
- Custom Gene-Targeting drug offers hope for one child with fatal brain disorder Results expected Feb 2027 (estimated)
- Custom-Made genetic drug tested in single ALS patient Results expected Mar 2027 (estimated)